Zimmer Biomet Holdings, Inc. (ZBH) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$82.83
Price Target
$97.90
Target Range
$83.00 — $120.00
Analyst Rating
Hold
Forward P/E9.8x
Trailing P/E23.3x
Forward PEG—
Implied Growth+118.1%
Median Target$93.50
Analyst Spread37.8%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$83
+0.2%
Consensus
$98
+18.2%
Bull Case
$120
+44.9%
Valuation Model TargetsConfidence: 57/100
Bear$10
Base$160
Bull$127
ZBH Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Zimmer Biomet Holdings, Inc. (ZBH) has a Wall Street consensus price target of $97.90, based on estimates from 42 covering analysts. With the stock currently trading at $82.83, this represents a potential upside of +18.2%. The company has a market capitalization of $16.22B.
Analyst price targets range from a low of $83.00 to a high of $120.00, representing a 38% spread in expectations. The median target of $93.50 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 18 analysts rating the stock as a Buy or Strong Buy,21 rating it Hold, and 3 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, ZBH trades at a trailing P/E of 23.3x and forward P/E of 9.8x. Analysts expect EPS to grow +118.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $159.82, with bear and bull scenarios of $10.17 and $127.23 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+54.8%
Avg Forward P/E17.4x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SYKStryker Corporation | $112.0B | $292.33 | $403.69 | +38.1% | Buy | 19.5x | 50 |
 BSXBoston Scientific Corporation | $83.2B | $56.00 | $91.33 | +63.1% | Buy | 16.6x | 43 |
 MDTMedtronic plc | $99.5B | $77.60 | $109.50 | +41.1% | Buy | 14.1x | 49 |
 SNNSmith & Nephew plc | $12.8B | $30.26 | $32.00 | +5.8% | Hold | 13.5x | 22 |
 GMEDGlobus Medical, Inc. | $12.1B | $89.22 | $110.67 | +24.0% | Buy | 20.0x | 36 |
 JNJJohnson & Johnson | $541.3B | $224.62 | $249.27 | +11.0% | Buy | 19.4x | 40 |
 ATECAlphatec Holdings, Inc. | $1.1B | $6.99 | $25.00 | +257.7% | Buy | 24.4x | 16 |
 XTNTXtant Medical Holdings, Inc. | $81M | $0.58 | — | — | — | — | — |
 OFIXOrthofix Medical Inc. | $489M | $12.19 | $18.00 | +47.7% | Hold | — | 17 |
 AHCOAdaptHealth Corp. | $1.6B | $11.40 | $12.00 | +5.2% | Buy | 11.4x | 12 |
Upside Potential Comparison
ATECBSXOFIXMDTSYKGMEDJNJSNNFull ZBH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ZBH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZBH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZBH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZBH — Frequently Asked Questions
Quick answers to the most common questions about buying ZBH stock.
What is the ZBH stock price target for 2026?
Zimmer Biomet Holdings, Inc. (ZBH) has a consensus 12-month price target of $97.9, implying 18.2% upside from $82.83. The 42 analysts covering ZBH see moderate appreciation potential.
Is ZBH a buy, sell, or hold?
ZBH has a consensus rating of "Hold" based on 42 Wall Street analysts. The rating breakdown is mixed, with 21 Hold ratings making up the largest segment. The consensus 12-month price target of $97.9 implies 18.2% upside from current levels.
Is ZBH stock overvalued or undervalued?
With a forward P/E of 9.7683x, ZBH trades at a relatively low valuation. The consensus target of $97.9 implies 18.2% appreciation, suggesting meaningful undervaluation.
How high can ZBH stock go?
The most bullish Wall Street analyst has a price target of $120 for ZBH, while the most conservative target is $83. The consensus of $97.9 represents the median expectation. Our quantitative valuation model projects a bull case target of $127 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ZBH stock?
ZBH is heavily covered by Wall Street, with 42 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 21 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ZBH stock forecast?
The 12-month ZBH stock forecast based on 42 Wall Street analysts shows a consensus price target of $97.9, with estimates ranging from $83 (bear case) to $120 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $160, with bear/bull scenarios of $10/$127.
What is ZBH's fair value based on fundamentals?
Our quantitative valuation model calculates ZBH's fair value at $160 (base case), with a bear case of $10 and bull case of $127. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.
What is ZBH's forward P/E ratio?
ZBH trades at a forward P/E ratio of 9.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ZBH stock?
Wall Street analysts are optimistic on ZBH, with a "Hold" consensus rating and $97.9 price target (18.2% upside). 18 of 42 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ZBH price targets vary so much?
ZBH analyst price targets range from $83 to $120, a 38% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $97.9 consensus represents the middle ground. Our model's $10-$127 range provides an independent fundamental perspective.